96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
PEPTIDES HAVING AFFINITY FOR BODY SURFACES
#5102Hydroxyapatite-binding peptides for bone growth and inhibition
#5103Fluorous capping reagents and methods for peptide purification
#5104Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
#5105Peptides that antagonize FPR class receptor mediated signaling
#5106Treating stroke and other diseases without inhibiting N-type calcium channels
#5107Polynucleotides encoding proteins for covalent tethering to functional groups and substrates
#5108Hla-A2 Tumor Associated Antigen Peptides and Compositions
#5109Heat shock protein-based vaccines and immunotherapies
#5110FGF-5 Supported and Binding Peptides
#5111METHOD OF USE OF PEPTIDE ANTAGONISTS OF ZONULIN TO PREVENT OR DELAY THE ONSET OF DIABETES
#5112Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
#5113Peptide inhibitors for mediating stress responses
#5114Imaging agents
#5115Triazole macrocycle systems
#5116Acid Addition Salts of Ac-Phscn-Nh2
#5117HLA binding motifs and peptides and their uses
#5118IL-15 mutants having agonists/antagonists activity
#5119Cyanine-based probe\tag-peptide pair for fluorescence protein imaging and fluorescence protein imaging methods
#5120Anti-EphB2 antibodies and methods using same
#5121Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
#5122METHODS OF MAKING AND USING SURFACTANT POLYMERS
#5123Activation of peptide prodrugs by hK2
#5124Convergent Solid Phase Peptide Synthesis By Reaction Of Two Fragments Bound To Solid Support
#5125Growth hormone releasing peptides
#5126HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS
#5127Antineoplastic peptides
#5128Cell Penetrating Peptides
#5129Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)
#5130Pro-angiogenic peptides
#5131Compositions and Methods for Treatment of Protein Misfolding and Protein Aggregation Diseases
#5132EphA2 T-cell epitopes and uses therefor
#5133Compositions and methods for the control of mammary cell number
#5134Hiv Prodrugs Cleavable by Cd26
#5135Small peptides and methods for inhibiting the infiltration of eosinophils into airways
#5136Small Peptides And Methods For Inhibiting The Migration Of T-Cells
#5137Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#5138Small peptides and methods for inhibiting mucus release into airways
#5139Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#5140Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease
#5141Small Peptides And Methods For Treatment Of Arthritis
#5142Pin1-modulating compounds and methods of use thereof
#5143Biologically active peptides and their new uses
#5144Compositions and methods for nucleic acid delivery
#5145Albumin fusion proteins
#5146Polynucleotides encoding chimeric GFP-aequorin as bioluminescent Ca++ reporters
#5147Digital alloys and methods for forming the same
#5148Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#5149Compositions for Targeting Amine Oxidases in Vivo
#5150Polytetrafluoroethylene binding peptides and methods of use
#5151PHARMACEUTICAL COMPOSITIONS OF HYDROMORPHONE FOR PREVENTION OF OVERDOSE OR ABUSE
#51522-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators
#5153Synthetic peptides and methods of use for autoimmune disease therapies
#5154IAP BIR domain binding compounds
#5155Antimicrobial Peptides
#5156Scaffold polypeptides for heterologous peptide display
#5157Anti-Angiogenic Peptides and Methods of Use Thereof
#5158HA-1 epitopes and uses thereof
#5159Peptides derived from human BPLP protein
#5160Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#5161Peptidomimetic agents from dextrorotatory amino acids as well as pharmaceutical agents that contain the latter for treatment of neurodegenerative diseases
#5162Trophinin-binding peptides and uses thereof
#5163Method For Screening Modulators of Mitochondrial Functioning and New Modulators Obtained
#5164Compositions for the detection of enzyme activity in biological samples and methods of use thereof
#5165Polypeptides having brain-localizing activity and uses thereof
#5166NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#5167Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
#5168Activatable photodynamic therapy agents
#5169Small Peptides And Methods For Stabilizing The Cell Membrane Of An Immune Cell
#5170Peptide-based compounds
#5171PEPTIDE DERIVATIVES, AND THEIR USE FOR THE SYNTHESIS OF SILICON-BASED COMPOSITE MATERIALS
#5172Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species
#5173Process for the Preparation of Peptides
#5174Combinatorial artificial receptors including peptide building blocks
#5175Macrocylic oximyl hepatitis C protease inhibitors
#5176Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity
#5177Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#5178VEGFR-1 TARGETING PEPTIDES
#5179Recombinant Production of Polyanionic Polymers, and Uses Thereof
#5180MN Gene and Protein
#5181Gene regulator
#5182Self-assembling peptide amphiphiles
#5183Compositions and methods for fusion protein separation
#5184Treatment of burns
#5185Method and composition for treating or prevending an oral cavity
#5186Selectively targeted antimicrobial peptides and the use thereof
#5187Disheveled PDZ modulators
#5188Peptide inhibitors of protein kinase C
#5189Albumin Fusion Proteins
#5190Albumin fusion proteins comprising insulin polypeptides
#5191RECEPTOR-MEDIATED UPTAKE OF PEPTIDES THAT BIND THE HUMAN TRANSFERRIN RECEPTOR
#5192Albumin Fusion Proteins
#5193C5a Receptor Antagonist
#5194Plasma protein-binding ligands
#5195Immunotherapeutic methods using epitopes of WT-1 and GATA-1
#5196Pharmaceutical Preparation For the Oral Cavity
#5197Treatment methods using polypeptides related to amyloid precursor protein
#5198G-CSF-albumin fusion proteins
#5199EPITOPES FORMED BY NON-COVALENT ASSOCIATION OF CONJUGATES
#5200Anti-Angiogenic Compounds
#5201Peptide-based conditioners and colorants for hair, skin, and nails
#5202Peptide-based oral care surface reagents for personal care
#5203Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
#5204Albumin fusion proteins
#5205IL-10 Related Peptides For Wound Healing
#5206Isolating biological modulators from biodiverse gene fragment libraries
#5207CONJUGATES OF RGD PEPTIDES AND PORPHYRIN OR (BACTERIO) CHLOROHYLL PHOTOSYNTHESIZERS AND THEIR USES
#5208Peptide capable of binding to insulin-binding protein and adsorbent
#5209Neuromedin B and somatostatin receptor agonists
#5210Peptide compositions for targeting adipose tissue
#5211Kahalalide compositions
#5212TPO peptide compounds for treatment of anemia
#5213Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#5214Polypeptide ligands for targeting cartilage and methods of use thereof
#5215Peptide compound for measuring sulfur compound and ammonia
#5216AGONIST POLYPEPTIDE OF RECEPTOR FOR ZOT AND ZONULIN
#5217Tgfbeta Supported and Binding Peptides
#5218Kits and peptides for transferases
#5219S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis
#5220Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
#5221HYD1 peptides as anti-cancer agents
#5222PEPTIDE-BASED CONDITIONERS
#5223Glycopeptide derivatives and pharmaceutical compositions containing the same
#5224Peptides That Stimulate Cell Survival and Axon Regeneration
#5225Prosaposin as a neurotrophic factor
#5226Composition and methods for promoting wound healing and tissue regeneration
#5227ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#5228Substrates and Assays for Beta Secretase Activity
#5229Flexibly labeling peptides
#5230Fluorescence assay for kinase activity
#5231Peptidomimetic modulators of cell adhesion
#5232Antibodies to a paralytic peptide
#5233Paralytic Peptide For Use In Neuromuscular Therapy
#5234Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated
#5235Antibacterial amide macrocycles IV
#5236IMMUNOREGULATORY COMPOSITIONS
#5237Stabilized calcium phosphate complexes
#5238TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY
#5239PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS
#5240Thrombopoietic compounds
#5241IAP BIR domain binding compounds
#5242Methods and Agents for the Treatment of Cancer
#5243Deoxonadepsipeptides
#5244Substituted nonadepsipeptides
#5245METHODS FOR CARBOXYPEPTIDASES
#5246Tumour-associated peptides binding to MHC-molecules
#5247Hemiasterlin derivatives and uses thereof in the treatment of cancer
#5248Heterocyclyl-substituted nonadepsipeptides
#5249PKC ligands and polynucleotides encoding PKC ligands
#5250Method for treating or inhibiting intestinal inflammation
#5251Tumour-associated peptides binding to MHC-molecules
#5252Hair growth promoting oligopeptides
#5253Antibodies to TGF-beta 1
#5254Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#5255Paralytic Peptide For Use In Neuromuscular Therapy
#5256Receptor modulators
#5257Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists
#5258Peptides and peptidomimetics binding to CD23
#5259Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof
#5260Unstructured recombinant polymers and uses thereof
#5261Dioxin-Binding Material and Method of Detecting or Quantifying Dioxin
#5262Method for identifying and quantifying of tumuor-associated
#5263Peptide motifs for binding avidin or neutravidin
#5264Tumor antigens
#5265REDOX-STABLE, NON-PHOSPHORYLATED CYCLIC PEPTIDE INHIBITORS OF SH2 DOMAIN BINDING TO TARGET PROTEIN, CONJUGATES, THEREOF, COMPOSITIONS AND METHODS OF SYNTHESIS AND USE
#5266PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
#5267Methods for the specific preparation of lysobactin fragments
#5268Modulators of protein phosphatase 2A and PP2A methyl esterase
#5269Peptides of Syndecan-1 For Inhibiting Angiogenesis
#5270Method of sequestering and/or purifying a polypeptide
#5271Antigen mimotopes and vaccine against cancerous diseases
#5272Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity
#5273Multimeric Fc receptor polypeptides
#5274Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
#5275Endometriosis cell targeting peptide and uses thereof
#5276Peptides and chemical compound for inhibition of SHP2 function
#5277GRP78 targeting peptides and methods employing same
#5278Inhibitors of IAP
#5279CEACAM based antibacterial agents
#5280Compositions and method for regulating ubiquitin-specific processing proteases
#5281Compositions and methods for promoting myocardial and peripheral angiogenesis
#5282Peptide mediated synthesis of metallic and magnetic materials
#5283Macrocylic oximyl hepatitis C protease inhibitors
#5284Metal-binding motif compositions and methods
#5285Peptide ligands for Bacillus anthracis spore detection
#5286Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
#5287Prodrugs cleavable by CD26
#5288Epo Mimetic Peptides and Fusion Proteins
#5289Amino Acid Sequences Essential to Neuron Specific Gene Expression
#5290Biologically active peptide PTTKTYFPHF
#5291PEPTIDE-BASED BODY SURFACE COLORING REAGENTS
#5292Diameter-selective reversible closable peptides
#5293PMMA binding peptides and methods of use
#5294Compounds that modulate TRH actions
#5295Peptides That Bind To Atherosclerotic Lesions
#5296Polystyrene binding peptides and methods of use
#5297Albumin fusion proteins
#5298Diagnostic and therapeutic agents
#5299Peptides that block the binding of IgG to FcRn
#5300Protein kinase inhibitors and methods for identifying same
#5301Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
#5302Agent for the treatment and/or prophylaxis of microcirculatory disorders
#5303Clay-binding peptides and methods of use
#5304High-throughput screening method for intergrin antagonist and new peptide screened therefrom
#5305Modulators of beta-amyloid peptide aggregation comprising D-amino acids
#5306Compositions and methods related to profiling a plurality of cells based on peptide binding
#5307Strains belonging to the genus Paenibacillus and method of controlling plant disease by using these strains or culture thereof
#5308Albumin fusion proteins
#5309Methods for reducing nasopharyngeal colonization of non-typable with synthetic chimeric fimbrin peptides
#5310Biologically Active Peptides
#5311COVALENT CONJUGATES BETWEEN ENDOPEROXIDES AND TRANSFERRIN AND LACTOFERRIN RECEPTOR-BINDING AGENTS
#5312Peptide conjugates
#5313C-REACTIVE PROTEIN APHERESIS
#5314Methods of treatment using specific binding agents of human angiopoietin-2
#5315Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
#5316Immune-modulating peptide
#5317Compositions capable of reducing elevated blood urea concentration
#5318Lymphatic zip codes in tumors and pre-malignant lesions
#5319Compositions and methods for enhancing drug delivery across and into ocular tissues
#5320Epithelial cell growth promoter
#5321Synuclein Mutant Having Aggregation-Inhibitory Activity
#5322Peptide Inhibitors of Matrix Metalloproteinase Activity
#5323COMPOUNDS AND METHODS FOR MODULATING ADHESION MOLECULE FUNCTION
#5324Compounds for control of appetite
#5325Peptidyl diacylglycerides
#5326Conjugates And Therapeutic Uses Thereof
#5327Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids
#5328Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
#5329Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
#5330Anti-glypican 3 antibody
#5331Method for stabilizing oil-based thickening gel composition
#5332Peptide-Based Multimeric Targeted Contrast Agents
#5333Crystalline form of a drug
#5334Compositions and methods for treatment of protein misfolding and protein aggregation diseases
#5335Antiproliferative peptides and antibodies for their detection
#5336peptides for bacterial interference
#5337Cell death modulation via antagonists of Fasl and Fas activation
#5338METHODS FOR TRANSFERASES
#5339Beta-secretase substrates and uses thereof
#5340Compositions and methods for enhancing drug delivery across and into epithelial tissues
#5341Inhibitors of glycinamide ribonucleotide transformylase
#5342Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity
#5343Peptide with putative role in cytoskeletal protection
#5344Hydrogels for modulating cell migration and matrix deposition
#5345Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
#5346Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#5347Conformationally restricted polyamine analogs as disease therapies
#5348Methionine aminopeptidase-2 inhibitors and methods of use thereof
#5349Methods and compositions for diagnosis and treatment of influenza
#5350VIRAL PROTEASE
#5351Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
#5352Tumor activated prodrugs
#5353Amylin aggregation inhibitors and use thereof
#5354Beta secretase exosite binding peptides and methods for identifying beta secretase modulators
#5355Peptides that home to tumor lymphatic vasculature and methods of using same
#5356D-amino acid peptides
#5357Thrombopoietic compounds
#5358Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)
#5359Nylon binding peptides and methods of use
#5360Polyethylene binding peptides and methods of use
#5361Targeting compositions and preparation therof
#5362Stabilizing peptides
#5363Rapamycin peptides conjugates: synthesis and uses thereof
#5364Method and peptide for regulating cellular activity
#5365Molecular libraries
#5366Substrates, sensors, and methods for assessing conditions in females
#5367Amniotic-derived peptide and uses thereof
#5368Peptide anti-tumor agent
#5369Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#5370Method for activating T cell protein tyrosine phosphatase for therapeutic applications
#5371Peptides capable of binding to titanium silver silicone
#5372Fibrin targeted therapeutics
#5373PROCESS FOR PREPARING VAPREOTIDE
#5374Peptide-based organic sunscreens
#5375Inhibitors of serine proteases
#5376Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof
#5377Methods of screening molecular libraries and active molecules identified thereby
#5378Antibacterial macrocycles with substituted biphenyl
#5379Specific binding sites in collagen for integrins and use thereof
#5380Comparative ligand mapping from MHC class I positive cells
#5381Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same
#5382Methods of treatment using specific binding agents of human angiopoietin-2
#5383Methods of treatment using specific binding agents of human angiopoietin-2
#5384Pharmaceutical composition comprising cyclic somatostatin analogues
#5385Processes and intermediates
#5386Peptides, derivatives and analogs thereof, and methods of using same
#5387Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#5388Delivery peptides, their constructs with active agents and use
#5389HLA-A24-restricted cancer antigen peptides
#5390Peptide increasing fusiogenic capacity of a gamete
#5391Peptides for enhanced cell attachment and growth
#5392Antimicrobial and anticancer lipopeptides
#5393Inhibitor of the folding of the HIV-1-protease as antiviral agent
#5394Methods of treatment using specific binding agents of human angiopoietin-2
#5395Glycogen synthase kinase-3 inhibitors
#5396In vivo imaging using peptide derivatives
#5397Composition for oral cavity
#5398Non-toxic membrane-translocating peptides
#5399Modified transferrin fusion proteins
#5400Apo2l(trail) receptor binding peptides and uses thereof